InterventionsHumans30,292 participantsCohort study

Tirzepatide and the risk of asthma exacerbations in patients with type 2 diabetes

Figure 1. The algorithm for patient selection. — Figure 1. The algorithm for patient selection.The algorithm for patient selection.Liao et al.

Frontiers in Endocrinology

The paper

Kuang‐Ming Liao, Chia-Yu Kuo, Jheng‐Yan Wu,

Wan‐Hsuan Hsu, Ya‐Wen Tsai,

Chih‐Cheng Lai

Min-Hwei College of Health Care Management · National Sun Yat-sen University

Frontiers in Endocrinology · 25 Aug 2026

doi.org/10.3389/fendo.2026.1928877 PubMed 42712413

GLP-1 agonists linked to lower dementia risk after COVID-19
Drug Design, Development and Therapy · 5 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Clinical Journal of the American Society of Nephrology · 4 Oct 2026
Diabetes drug class linked to slightly less frailty progression
Diabetes, Obesity & Metabolism · 8 Oct 2026